| __timestamp | Celldex Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 1802274 |
| Thursday, January 1, 2015 | 33837000 | 2512761 |
| Friday, January 1, 2016 | 35979000 | 2894488 |
| Sunday, January 1, 2017 | 25003000 | 8096274 |
| Monday, January 1, 2018 | 19269000 | 7985229 |
| Tuesday, January 1, 2019 | 15426000 | 8994597 |
| Wednesday, January 1, 2020 | 14456000 | 29772000 |
| Friday, January 1, 2021 | 20488000 | 33907000 |
| Saturday, January 1, 2022 | 27195000 | 26579000 |
| Sunday, January 1, 2023 | 30914000 | 49868547 |
Data in motion
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and Celldex Therapeutics, Inc. over the past decade, from 2014 to 2023.
Celldex Therapeutics, Inc. has shown a relatively stable SG&A expense trend, with a notable peak in 2016, where expenses reached approximately 36 million. In contrast, Verona Pharma plc's SG&A expenses have surged dramatically, especially in recent years, culminating in a 2023 figure that is nearly 28 times higher than in 2014. This sharp increase suggests a strategic shift, possibly towards aggressive market expansion or increased R&D investments.
These trends highlight the differing financial strategies of these companies, offering insights into their operational priorities and market positioning.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Celldex Therapeutics, Inc.
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
MannKind Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.